New Merck Company Begins Operations
US - Merck has outlined its global plans following the completion of Merck's merger with Schering-Plough Corporation announced this week. Raul E. Kohan has been named president of the Animal Health division.

Merck, Schering-Plough Merger Approved
GLOBAL - Merck and Schering-Plough have received approvals from the US Federal Trade Commission, Swiss Competition Commission and Canadian Competition Bureau for their proposed merger but significant divestitures are required.

Claassen Receives Dieter Lütticken Award
ITALY - The Dieter Lütticken Award 2008 for alternatives into animal testing has been presented to Dr Ivo Claassen of the Netherlands.

Schering-Plough Shareholders Approve Merger With Merck
US - Schering-Plough Corporation has announced that its shareholders have overwhelmingly approved the merger with Merck.

INNOVAX-ILT Protects against ILT for 60 Weeks
US - INNOVAX®-ILT, an innovative recombinant vaccine, protects chickens against infectious laryngotracheitis (ILT) for at least 60-weeks, according to a study recently accepted by the United States Department of Agriculture.

I/SPAH Adds Food Industry Staff
US - Jennie Hodgen, Ph.D., and Bob Giblin, APR, have joined Intervet/Schering-Plough Animal Health (I/SPAH) in two newly created positions established to develop the animal health company's relationships within the food chain.

INNOVAX Vaccines Now Available in Latin America
GLOBAL - Intervet/Schering Plough Animal Health's new Innovax poultry vaccine range is now available in Latin America.

Schering-Plough Flips Switch on 1.7MW Solar System
US - Animal health and pharmaceuticals giant, Schering-Plough Corporation, has switched on a 1.7 megawatt solar energy system on the roof of its centre in New Jersey.

I/SPAH Sponsors New Web Site
NETHERLANDS - Intervet/Schering-Plough Animal Health has announced it is sponsoring a peer-reviewed web site on chicken anemia virus.

Merck and Schering-Plough to Merge
GLOBE - Merck & Co., Inc. and Schering-Plough Corporation today announced that their Boards of Directors have unanimously approved a definitive merger agreement under which Merck and Schering-Plough will combine, under the name Merck, in a stock and cash...

Intervet/Schering-Plough Names Poultry Teams
GLOBAL - Following the recent re-organisation in Intervet/Schering-Plough Animal Health to focus on disease, the company has announced a number of appointments for its Global Poultry Business Unit.

Intervet/Schering-Plough Re-Focuses on Disease
GLOBAL - Intervet/Schering-Plough Animal Health has announced that it will focus on four areas of poultry disease management in future.

New Facility Open for Innovative Poultry Vaccine Technology
THE NETHERLANDS - Intervet/Schering-Plough Animal Health announces the opening of its new Sphereon vaccine manufacturing facility in Boxmeer.

Intervet/Schering-Plough Animal Health Update New Business
US – Leaders from the US division of Intervet/Schering-Plough Animal Health discussed the new combined company at an event held at this year’s North American Veterinary Conference.

Schering-Plough Announces Transition of Animal Health Leadership
US – Schering-Plough Corporation has announced the transition of leadership of its Animal Health unit from Ruurd Stolp, D.V.M., Ph.D., to Raul E. Kohan, who was previously the Deputy Head of the Animal Health unit.

Web Seminar on Controlling Salmonella in Poultry
UK - Intervet/Schering Plough animal health is broadcasting a web seminar focusing on the control of Salmonella in poultry.

Intervet/Schering-Plough Animal Health Appoints Heads of Global Poultry
US – Intervet/Schering-Plough Animal Health appointed the Heads of Global Species teams for the swine, the poultry and the aquaculture segment.

Intervet / Schering Plough Animal Health at VIV Europe in Moscow
RUSSIA - Animal health company Intervet / Schering Plough Animal Health is to present the new combined company to a large audience for the first time at the VIV Europe in Moscow.

Intervet/Schering-Plough Animal Health appoints Executive Team
THE NETHERLANDS – Schering-Plough appointed the Executive Team members of the company’s global animal health unit: Intervet / Schering- Plough Animal Health. These appointments define the major steps in the design process of the animal health unit. The...

Schering-Plough Completes Acquisition of Organon BioSciences
KENILWORTH - Combination Expands Human Health Business, Creates a Global Leader in Animal Health and Strengthens Product Pipeline, Adding Five Phase III Projects

New Fowlpox Vaccine Available
AUSTRALIA - A new vaccine developed by CSIRO Livestock Industries to help control the common poultry disease, fowlpox, has been registered for commercial use by one of Australia’s leading animal health companies, Intervet Australia Pty Ltd.

Third Quarter Results Confirm SPs Solid Position
NEW JERSEY - The finances of world-leading pharmaceutical giant Schering-Plough are very much in order. The company has recorded its 12th consecutive quarter of double-digit adjusted sales growth putting it in prime position for the integration of the...

Euro Approval For The World's Largest Animal Health Business
EUROPE - Schering-Plough Corporation has received European Commission approval for its planned acquisition of Organon BioSciences, from Akzo Nobel.

Genome Sequence Of Stable Campylobacter Strain Deciphered
NORWICH - Scientists of the Institute of Food Research and their collaborators at the veterinary pharmaceutical company Intervet have deciphered and published the complete genome sequence of a strain of Campylobacter jejuni.

Schering-Plough Animal Health Expands Poultry Portfolio With Addition Of Aviguard
GLOBAL - Schering-Plough Animal Health has confirmed that it has secured agreement with Microbial Developments Ltd (MDL) to become sole supplier of Aviguard, the leading natural gut flora product for poultry.